The Late Arrival of Coronavirus Disease 2019 (COVID-19) in Africa: Mitigating Pan-continental Spread
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The novel coronavirus disease 2019 (COVID-19) has rapidly spread to all 7 continents. Due to yet unknown reasons, the African continent has remained relatively unaffected. We discuss the importance of mitigating pan-continental spread in light of the fragile healthcare systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“this may be because COVID-19 has had a relatively low overall impact on health within the continent to date [31]”
From Use of Telehealth During the COVID-19 Pandemic: Scoping Review (2020) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedA Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Dong, L., Hu, S., & Gao, J. (2020) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2020.01012 · Cited by 1,390
The role of absolute humidity on transmission rates of the COVID-19 outbreak
Luo, W., Majumder, M. S., Liu, D., Poirier, C., Mandl, K. D., Lipsitch, M., & Santillana, M. (2020) · medRxiv · doi:10.1101/2020.02.12.20022467 · Cited by 239
Kapata, N., Ihekweazu, C., Ntoumi, F., Raji, T., Chanda-Kapata, P., Mwaba, P., Mukonka, V., Bates, M., Tembo, J., Corman, V., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.02.049 · Cited by 195
Self-citationHaider, N., Yavlinsky, A., Simons, D., Osman, A. Y., Ntoumi, F., Zumla, A., & Kock, R. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820000424 · Cited by 139
Self-citationMobile health applications for HIV prevention and care in Africa
Forrest, J. I., Wiens, M., Kanters, S., Nsanzimana, S., Lester, R. T., & Mills, E. J. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000198 · Cited by 59
EBOLA and FDA: reviewing the response to the 2014 outbreak, to find lessons for the future
Largent, E. A. (2016) · Journal of Law and the Biosciences · doi:10.1093/jlb/lsw046 · Cited by 38
Research works printed but not linked: 1
- Rory Leisegang R, Calkins K, Cotton M, et al HIV-positive patients receiving antiretrovirals through home delivery: does it matter? A causal analysis. Poster 5543. Presented at: Conference on Retroviruses and Opportunistic Infection; March 6–11, 2020; Boston, MA, USA.
Cited by
Ranking the effectiveness of worldwide COVID-19 government interventions
Haug, N., Geyrhofer, L., Londei, A., Dervic, E., Desvars-Larrive, A., Loreto, V., Pinior, B., Thurner, S., & Klimek, P. (2020) · Nature Human Behaviour · doi:10.1038/s41562-020-01009-0 · Cited by 1,412
Use of Telehealth During the COVID-19 Pandemic: Scoping Review
Doraiswamy, S., Abraham, A., Mamtani, R., & Cheema, S. (2020) · Journal of Medical Internet Research · doi:10.2196/24087 · Cited by 698
“Interestingly, we found no publication originating from Africa; this may be because COVID-19 has had a relatively low overall impact on health within the continent to date [31] and the fact that telehealth infrastructure availability is limited in many African countries [32].”
COVID-19 pandemic – an African perspective
Lone, S. A., & Ahmad, A. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1775132 · Cited by 579
How COVID-19 has fundamentally changed clinical research in global health
Park, J. J. H., Mogg, R., Smith, G. E., Nakimuli-Mpungu, E., Jehan, F., Rayner, C. R., Condo, J., Decloedt, E. H., Nachega, J. B., Reis, G., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30542-8 · Cited by 218
Self-citationBates, B. R., Moncayo, A. L., Costales, J. A., Herrera, C., & Grijalva, M. J. (2020) · Journal of Community Health · doi:10.1007/s10900-020-00916-7 · Cited by 116
Metadata
- Authors
- Nachega, J., Seydi, M., & Zumla, A.
- Affiliations
- Johns Hopkins University (US)
- Centre Hospitalier National Universitaire de Fann (SN)
- National Institute for Health and Care Research (GB)
- Corresponding author
- Nachega, Jean
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-03-30
- Volume
- 71
- Issue
- 15
- Pages
- 875-878
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC7184327
- OpenAlex
- W3013325413
- Cited by
- 76
- References
- 8
- Citations by year
- 2025: 3 · 2024: 6 · 2023: 10 · 2022: 7 · 2021: 21 · 2020: 29
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- SUNScholar (Stellenbosch University) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (5U01AI069521)
- Fogarty International Center (1R25TW011217-01)
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 pandemic, SARS-CoV-2, Africa, pandemic mitigation, epidemic spread
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Adult, Africa, Female, Humans, Male, Middle Aged, Pneumonia, Viral, World Health Organization, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.